Dexcom Inc
(DXCM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 623,200 | 642,300 | 698,100 | 735,400 | 716,000 |
| Marketable Securities | 1,943,800 | 1,813,900 | 1,673,800 | 2,019,400 | 1,972,200 |
| Receivables | 636,800 | 713,300 | 564,100 | 560,800 | 544,500 |
| Inventories | 366,000 | 306,700 | 311,000 | 339,500 | 342,200 |
| TOTAL | $3,767,400 | $3,668,800 | $3,398,500 | $3,808,700 | $3,746,600 |
| Non-Current Assets | |||||
| PPE Net | 1,075,500 | 1,055,600 | 1,002,500 | 942,900 | 856,500 |
| Intangibles | 189,300 | 199,000 | 49,100 | 53,600 | 58,000 |
| Other Non-Current Assets | 483,700 | 468,300 | 449,100 | 412,200 | 395,900 |
| TOTAL | $1,748,500 | $1,722,900 | $1,500,700 | $1,408,700 | $1,310,400 |
| Total Assets | $5,515,900 | $5,391,700 | $4,899,200 | $5,217,400 | $5,057,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 772,600 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 965,200 | 901,800 | 764,200 | 688,300 | 603,100 |
| Accrued Expenses | 94,800 | 134,300 | 112,700 | 94,800 | 84,700 |
| TOTAL | $1,865,000 | $1,839,300 | $900,500 | $807,000 | $711,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,198,500 | 1,197,700 | 1,968,800 | 1,967,300 | 1,965,900 |
| Deferred Revenues | 9,600 | 10,100 | 2,700 | 2,700 | 2,700 |
| Other Non-Current Liabilities | 219,400 | 222,900 | 205,400 | 187,200 | 190,400 |
| TOTAL | $1,417,900 | $1,420,600 | $2,174,200 | $2,154,500 | $2,156,300 |
| Total Liabilities | $3,282,900 | $3,259,900 | $3,074,700 | $2,961,500 | $2,867,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 387,636 | 386,414 | 386,258 | 392,582 | 392,504 |
| Common Shares | 400 | 400 | 400 | 400 | 100 |
| Retained earnings | 528,500 | 479,900 | 388,100 | 286,900 | 236,000 |
| Other shareholders' equity | -6,500 | -11,600 | -41,100 | -23,300 | -6,400 |
| TOTAL | $2,233,000 | $2,131,800 | $1,824,500 | $2,255,900 | $2,189,300 |
| Total Liabilities And Equity | $5,515,900 | $5,391,700 | $4,899,200 | $5,217,400 | $5,057,000 |